Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Oncology Biosimilar
Sort By
Newest First
1 / 1
1 / 1
European Approval
Pfizer Receives European Approval for Oncology Biosimilar, TRAZIMERA™ (trastuzumab)
Pfizer
PR-M08-18-NI-014
Aug 06, 2018
